|
|
Article: Alk-Abello's Grazax for children launched in UK.(Brief article)
- Article from:
- Pharma Marketletter
- Article date:
- March 2, 2009
CopyrightCOPYRIGHT 2009 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Danish firm ALK-Abello's Grazax, a tablet-based immunotherapy product for grass pollen allergy, is now available for use in children and adolescents aged five to 17 in the UK.
Grazax is the only non-injection immunotherapy licensed to treat children suffering from severe grass pollen-induced seasonal allergic rhinitis and conjunctivitis or severe hay fever. In addition, it is the first immunotherapy tablet to address the underlying cause of grass pollen allergy. It is a once-daily, fast-melting tablet which is placed under the tongue. Grazax has been available ...